Circulating Biomarkers May Be Indicative of Stroke Risk

This article originally appeared here.
Share this content:
Circulating Biomarkers May Be Indicative of Stroke Risk
Circulating Biomarkers May Be Indicative of Stroke Risk

THURSDAY, Aug. 25, 2016 (HealthDay News) -- In the future, a simple blood test might gauge a patient's odds of incident ischemic stroke (IIS), according to a study published online Aug. 24 in Neurology.

A team of researchers measured levels of biomarkers in 3,224 individuals. The patients averaged 61 years of age and were tracked for an average of nine years. During that time, 98 of them did suffer IIS.

Elevated levels of four of the biomarkers were linked with increased IIS risk. High blood levels of homocysteine indicated a 32 percent higher risk compared to individuals with the lowest levels. And high levels of three other biomarkers -- vascular endothelial growth factor, C-reactive protein, and tumor necrosis factor receptor 2 -- also indicated a similar heightening of IIS risk, the investigators found.

"Identifying people who are at risk for stroke can help us determine who would benefit most from existing or new therapies to prevent stroke," lead author Ashkan Shoamanesh, M.D., of McMaster University in Hamilton, Canada, said in a journal news release.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

AAN: Alpha-Synuclein Levels in Tears May Help ID Parkinson's

AAN: Alpha-Synuclein Levels in Tears May Help ID ...

PD patients have significantly decreased total alpha-synuclein in tears compared with healthy controls

Younger Onset of T2DM Linked to Increased Mortality Risk

Younger Onset of T2DM Linked to Increased Mortality ...

Earlier diagnosis of T2DM tied to increased mortality, mainly driven by cardiovascular disease mortality

Menopausal Hormone Therapy Tied to Less Pronounced Kyphosis

Menopausal Hormone Therapy Tied to Less Pronounced Kyphosis

Continuous and remote past HT users had less kyphosis in minimally-, fully-adjusted models

is free, fast, and customized just for you!

Already a member?

Sign In Now »